News

Washington, D.C. (April 29, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released new evidence from the Select Subcommittee’s ongoing investigation into the Trump Administration’s political interference in the nation’s coronavirus response in advance of a hearing at 9:00 a.m. ET on ensuring scientific integrity in the nation’s public health agencies.  Consistent with a recent report from the Government Accountability Office (GAO)—which found that government scientists observed incidents of political interference in scientific decision-making but did not report them for fear of retaliation or because they believed superiors already knew—today’s evidence sheds new light on the extent to which Trump Administration officials overruled, undermined, and muzzled career public health experts during the critical first year of the pandemic.   

Washington, D.C. (April 25, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to Food and Drug Administration (FDA) Commissioner Dr. Robert M. Califf requesting a staff briefing on the status of coronavirus vaccine candidates for young children.

Washington, D.C. (April 14, 2022)—Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to ID.me CEO Blake Hall, requesting documents and information related to the company’s contracts with federal, state, and local governments for use of its facial recognition technology. The Chairs raised concerns with widespread issues related to ID.me’s services, including how ID.me’s technology may have undermined the effectiveness, efficiency, and equity of unemployment assistance programs during the coronavirus pandemic.

Washington, D.C. (March 30, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with senior Biden Administration officials to discuss the current phase of the pandemic, the Administration’s National COVID-19 Preparedness Plan, and how Americans would be impacted if Congress fails to provide the funding necessary to sustain and build on the progress made to date.